SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare - Quaterly Results

11 Feb 2022 Evaluate
The sales figure stood at Rs. 949.22 millions for the December 2021 quarter. The mentioned figure indicates a growth of about 44.88% as compared to Rs. 655.16 millions during the year-ago period.The company has announced a 43.36% increase in its profits to Rs . 121.53  millions for the  quarter ended December 2021 compared to Rs. 84.77 millions in the corresponding quarter in the previous year.Operating profit surged to 214.32 millions from the corresponding previous quarter of 155.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 949.22 655.16 44.88 3148.17 1688.96 86.40 2306.70 2015.88 14.43
Other Income 41.40 2.50 1556.00 47.02 27.40 71.61 36.22 34.71 4.35
PBIDT 214.32 155.10 38.18 859.31 400.17 114.74 535.05 391.53 36.66
Interest 21.25 29.23 -27.30 68.46 96.26 -28.88 127.12 128.80 -1.30
PBDT 193.07 125.87 53.39 790.85 303.91 160.23 407.93 262.73 55.27
Depreciation 23.65 20.87 13.32 70.90 61.65 15.00 85.46 82.68 3.36
PBT 169.42 105.00 61.35 719.95 242.26 197.18 322.47 180.05 79.10
TAX 47.89 20.23 136.73 179.87 44.24 306.58 56.28 20.93 168.90
Deferred Tax 7.89 20.23 -61.00 42.37 44.24 -4.23 56.28 20.93 168.90
PAT 121.53 84.77 43.36 540.08 198.02 172.74 266.19 159.12 67.29
Equity 91.99 91.89 0.11 91.99 91.89 0.11 91.88 91.88 0.00
PBIDTM(%) 22.58 23.67 -4.63 27.30 23.69 15.20 23.20 19.42 19.43

Themis Medicare Share Price

90.25 4.97 (5.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×